Development of the Vault Particle as a Platform Technology

ACS Nano

Volumn 7, Issue 2, 2013, Pages 889-902

  Rome, Leonard H ^a   Kickhoefer, Valerie A ^a  

^a CALIFORNIA NANOSYSTEMS INSTITUTE   (United States)

Author keywords

adjuvant; drug delivery; immunotherapy; INT (MVP interaction domain); major vault protein (MVP); nanoparticle; vaccine; vault

Indexed keywords

ADJUVANT; IMMUNOTHERAPY; INTERACTION DOMAIN; MAJOR VAULT PROTEINS; VAULT;

DRUG DELIVERY; PROTEINS; VACCINES;

NANOPARTICLES;

DRUG CARRIER; RIBONUCLEOPROTEIN; VACCINE;

ANIMAL; CHEMISTRY; GENETICS; HUMAN; IMMUNOTHERAPY; METABOLISM; METHODOLOGY; NANOTECHNOLOGY; PROTEIN ENGINEERING; REVIEW;

ANIMALS; DRUG CARRIERS; HUMANS; IMMUNOTHERAPY; NANOTECHNOLOGY; PROTEIN ENGINEERING; VACCINES; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 84874440702     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn3052082     Document Type: Review

References (105)

1. Kedersha, N. L.; Rome, L. H. Preparative Agarose Gel Electrophoresis for the Purification of Small Organelles and Particles Anal. Biochem. 1986, 156, 161-170
2. Kedersha, N. L.; Rome, L. H. Isolation and Characterization of a Novel Ribonucleoprotein Particle: Large Structures Contain a Single Species of Small RNA J. Cell Biol. 1986, 103, 699-709
3. Kickhoefer, V. A.; Stephen, A. G.; Harrington, L.; Robinson, M. O.; Rome, L. H. Vaults and Telomerase Share a Common Subunit, TEP1 J. Biol. Chem. 1999, 274, 32712-32717
4. Kickhoefer, V. A.; Siva, A. C.; Kedersha, N. L.; Inman, E. M.; Ruland, C.; Streuli, M.; Rome, L. H. The 193-Kd Vault Protein, VPARP, Is a Novel Poly(ADP-Ribose) Polymerase J. Cell Biol. 1999a, 146, 917-928
5. Kickhoefer, V. A.; Searles, R. P.; Kedersha, N. L.; Garber, M. E.; Johnson, D. L.; Rome, L. H. Vault Ribonucleoprotein Particles from Rat and Bullfrog Contain a Related Small RNA That Is Transcribed by RNA Polymerase III J. Biol. Chem. 1993, 268, 7868-7873
6. Kickhoefer, V. A.; Liu, Y.; Kong, L. B.; Snow, B. E.; Stewart, P. L.; Harrington, L.; Rome, L. H. The Telomerase/Vault-Associated Protein TEP1 Is Required for Vault RNA Stability and Its Association with the Vault Particle J. Cell Biol. 2001, 152, 157-164
7. Rome, L.; Kedersha, N.; Chugani, D. Unlocking Vaults: Organelles in Search of a Function Trends Cell Biol 1991, 1, 47-50
8. Kickhoefer, V. A.; Vasu, S. K.; Rome, L. H. Vaults Are the Answer, What Is the Question? Trends Cell Biol 1996, 6, 174-178
9. Suprenant, K. A. Vault Ribonucleoprotein Particles: Sarcophagi, Gondolas, or Safety Deposit Boxes? Biochemistry 2002, 41, 14447-14454
10. Van Zon, A.; Mossink, M. H.; Scheper, R. J.; Sonneveld, P.; Wiemer, E. A. The Vault Complex Cell. Mol. Life Sci. 2003, 60, 1828-1837
11. Steiner, E.; Holzmann, K.; Elbling, L.; Micksche, M.; Berger, W. Cellular Functions of Vaults and Their Involvement in Multidrug Resistance Curr. Drug Targets 2006, 7, 923-934
12. Berger, W.; Steiner, E.; Grusch, M.; Elbling, L.; Micksche, M. Vaults and the Major Vault Protein: Novel Roles in Signal Pathway Regulation and Immunity Cell. Mol. Life Sci. 2009, 66, 43-61
13. Liu, Y.; Snow, B. E.; Hande, M. P.; Baerlocher, G.; Kickhoefer, V. A.; Yeung, D.; Wakeham, A.; Itie, A.; Siderovski, D. P.; Harrington, L. et al. Telomerase-Associated Protein TEP1 Is Not Essential for Telomerase Activity or Telomere Length Maintenance in Vivo Mol. Cell. Biol. 2000, 20, 8178-8184
14. Liu, Y.; Snow, B. E.; Kickhoefer, V. A.; Erdmann, N.; Zhou, W.; Wakeham, A.; Gomez, M.; Rome, L. H.; Harrington, L. Vault Poly(ADP-Ribose) Polymerase Is Associated with Mammalian Telomerase and Is Dispensable for Telomerase Function and Vault Structure in Vivo Mol. Cell. Biol. 2004, 24, 5314-5323
15. Mossink, M. H.; Van Zon, A.; Franzel-Luiten, E.; Schoester, M.; Kickhoefer, V. A.; Scheffer, G. L.; Scheper, R. J.; Sonneveld, P.; Wiemer, E. A. Disruption of the Murine Major Vault Protein (MVP/LRP) Gene Does Not Induce Hypersensitivity to Cytostatics Cancer Res. 2002, 62, 7298-8304
16. Vasu, S. K.; Kedersha, N. L.; Rome, L. H. cDNA Cloning and Disruption of the Major Vault Protein Alpha Gene (MVPα) in Dictyostelium Discoideum J. Biol. Chem. 1993, 268, 15356-15360
17. Vasu, S. K.; Rome, L. H. Dictyostelium Vaults: Disruption of the Major Proteins Reveals Growth and Morphological Defects and Uncovers a New Associated Protein J. Biol. Chem. 1995, 270, 16588-16594
18. Kedersha, N. L.; Heuser, J. E.; Chugani, D. C.; Rome, L. H. Vaults. III. Vault Ribonucleoprotein Particles Open into Flower-like Structures with Octagonal Symmetry J. Cell Biol. 1991, 112, 225-235
19. Mikyas, Y.; Makabi, M.; Raval-Fernandes, S.; Harrington, L.; Kickhoefer, V. A.; Rome, L. H.; Stewart, P. L. Cryoelectron Microscopy Imaging of Recombinant and Tissue Derived Vaults: Localization of The MVP N Termini and VPARP J. Mol. Biol. 2004, 344, 91-105
20. Kedersha, N. L.; Miquel, M. C.; Bittner, D.; Rome, L. H. Vaults. II. Ribonucleoprotein Structures Are Highly Conserved among Higher and Lower Eukaryotes J. Cell Biol. 1990, 110, 895-901
21. Hamill, D. R.; Suprenant, K. A. Characterization of the Sea Urchin Major Vault Protein: A Possible Role for Vault Ribonucleoprotein Particles in Nucleocytoplasmic Transport Dev. Biol. 1997, 190, 117-128
22. Herrmann, C.; Volknandt, W.; Wittich, B.; Kellner, R.; Zimmermann, H. The Major Vault Protein (MVP100) Is Contained in Cholinergic Nerve Terminals of Electric Ray Electric Organ J. Biol. Chem. 1996, 271, 13908-13915
23. Anderson, D. H.; Kickhoefer, V. A.; Sievers, S. A.; Rome, L. H.; Eisenberg, D. Draft Crystal Structure of the Vault Shell at 9-Å Resolution PLoS Biol 2007, 5, E318
24. Tanaka, H.; Kato, K.; Yamashita, E.; Sumizawa, T.; Zhou, Y.; Yao, M.; Iwasaki, K.; Yoshimura, M.; Tsukihara, T. The Structure of Rat Liver Vault at 3.5 Angstrom Resolution Science 2009, 323, 384-388
25. Stephen, A. G.; Raval-Fernandes, S.; Huynh, T.; Torres, M.; Kickhoefer, V. A.; Rome, L. H. Assembly of Vault-like Particles in Insect Cells Expressing only the Major Vault Protein J. Biol. Chem. 2001, 276, 23217-23220
26. Kong, L. B.; Siva, A. C.; Kickhoefer, V. A.; Rome, L. H.; Stewart, P. L. RNA Location and Modeling of a WD40 Repeat Domain within the Vault RNA 2000, 6, 890-900
27. Kickhoefer, V. A.; Han, M.; Raval-Fernandes, S.; Poderycki, M. J.; Moniz, R. J.; Vaccari, D.; Silvestry, M.; Stewart, P. L.; Kelly, K. A.; Rome, L. H. Targeting Vault Nanoparticles to Specific Cell Surface Receptors ACS Nano 2009, 3, 27-36
28. Goldsmith, L. E.; Pupols, M.; Kickhoefer, V. A.; Rome, L. H.; Monbouquette, H. G. Utilization of a Protein "Shuttle" To Load Vault Nanocapsules with Gold Probes and Proteins ACS Nano 2009, 3, 3175-3183
29. Kickhoefer, V. A.; Garcia, Y.; Mikyas, Y.; Johansson, E.; Zhou, J. C.; Raval-Fernandes, S.; Minoofar, P.; Zink, J. I.; Dunn, B.; Stewart, P. L. et al. Engineering of Vault Nanocapsules with Enzymatic and Fluorescent Properties Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 4348-4352
30. Kozlov, G.; Vavelyuk, O.; Minailiuc, O.; Banville, D.; Gehring, K.; Ekiel, I. Solution Structure of a Two-Repeat Fragment of Major Vault Protein J. Mol. Biol. 2006, 356, 444-452
31. Poderycki, M. J.; Kickhoefer, V. A.; Kaddis, C. S.; Raval-Fernandes, S.; Johansson, E.; Zink, J. I.; Loo, J. A.; Rome, L. H. The Vault Exterior Shell Is a Dynamic Structure That Allows Incorporation of Vault-Associated Proteins into Its Interior Biochemistry 2006, 45, 12184-12193
32. Broo, K.; Wei, J.; Marshall, D.; Brown, F.; Smith, T. J.; Johnson, J. E.; Schneemann, A.; Siuzdak, G. Viral Capsid Mobility: A Dynamic Conduit for Inactivation Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 2274-2277
33. Bothner, B.; Dong, X. F.; Bibbs, L.; Johnson, J. E.; Siuzdak, G. Evidence of Viral Capsid Dynamics Using Limited Proteolysis and Mass Spectrometry J. Biol. Chem. 1998, 273, 673-676
34. Yang, J.; Kickhoefer, V. A.; Ng, B. C.; Gopal, A.; Bentolila, L. A.; John, S.; Tolbert, S. H.; Rome, L. H. Vaults Are Dynamically Unconstrained Cytoplasmic Nanoparticles Capable of Half Vault Exchange ACS Nano 2010, 4, 7229-7240
35. Goldsmith, L. E.; Yu, M.; Rome, L. H.; Monbouquette, H. G. Vault Nanocapsule Dissociation into Halves Triggered at Low pH Biochemistry 2007, 46, 2865-2875
36. Esfandiary, R.; Kickhoefer, V. A.; Rome, L. H.; Joshi, S. B.; Middaugh, C. R. Structural Stability of Vault Particles J. Pharm. Sci. 2008, 98, 1376-1386
37. Yu, M.; Ng, B. C.; Rome, L. H.; Tolbert, S. H.; Monbouquette, H. G. Reversible pH Lability of Cross-Linked Vault Nanocapsules Nano Lett. 2008, 8, 3510-3515
38. Ng, B. C.; Yu, M.; Gopal, A.; Rome, L. H.; Monbouquette, H. G.; Tolbert, S. H. Encapsulation of Semiconducting Polymers in Vault Protein Cages Nano Lett. 2008, 8, 3503-3509
39. Braisted, A. C.; Wells, J. A. Minimizing a Binding Domain From Protein A Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 5688-5692
40. Lai, C. Y.; Wiethoff, C. M.; Kickhoefer, V. A.; Rome, L. H.; Nemerow, G. R. Vault Nanoparticles Containing an Adenovirus-Derived Membrane Lytic Protein Facilitate Toxin and Gene Transfer ACS Nano 2009, 3, 691-699
41. Wiethoff, C. M.; Wodrich, H.; Gerace, L.; Nemerow, G. R. Adenovirus Protein VI Mediates Membrane Disruption Following Capsid Disassembly J. Virol. 2005, 79, 1992-2000
42. Han, M.; Kickhoefer, V. A.; Nemerow, G. R.; Rome, L. H. Targeted Vault Nanoparticles Engineered with an Endosomolytic Peptide Deliver Biomolecules to the Cytoplasm ACS Nano 2011, 5, 6128-6137
43. Kickhoefer, V. A.; Rajavel, K. S.; Scheffer, G. L.; Dalton, W. S.; Scheper, R. J.; Rome, L. H. Vaults Are Up-Regulated in Multidrug-Resistant Cancer Cell Lines J. Biol. Chem. 1998, 273, 8971-8974
44. Manolova, V.; Flace, A.; Bauer, M.; Schwarz, K.; Saudan, P.; Bachmann, M. F. Nanoparticles Target Distinct Dendritic Cell Populations According to Their Size Eur. J. Immunol. 2008, 38, 1404-1413
45. Zuercher, A. W.; Coffin, S. E.; Thurnheer, M. C.; Fundova, P.; Cebra, J. J. Nasal-Associated Lymphoid Tissue Is a Mucosal Inductive Site for Virus-Specific Humoral and Cellular Immune Responses J. Immunol. 2002, 168, 1796-1803
46. Mestecky, J. The Common Mucosal Immune System and Current Strategies for Induction of Immune Responses in External Secretions J. Clin. Immunol. 1987, 7, 265-276
47. Kozlowski, P. A.; Williams, S. B.; Lynch, R. M.; Flanigan, T. P.; Patterson, R. R.; Cu-Uvin, S.; Neutra, M. R. Differential Induction of Mucosal and Systemic Antibody Responses in Women after Nasal, Rectal, or Vaginal Immunization: Influence of the Menstrual Cycle J Immunol 2002, 169, 566-574
48. Champion, C. I.; Kickhoefer, V. A.; Liu, G.; Moniz, R. J.; Freed, A. S.; Bergmann, L. L.; Vaccari, D.; Raval-Fernandes, S.; Chan, A. M.; Rome, L. H. et al. A Vault Nanoparticle Vaccine Induces Protective Mucosal Immunity PLoS One 2009, 4, E5409
49. World Health Organization, Department of HIV/AIDS. Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections. http://www.who.int/reproductivehealth/publications/rtis/HIV-AIDS-2001-2/en/ index.html (accessed 2009), 2001.
50. Center for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 1999; US Department of Health and Human Services DoSP: Atlanta, Ga., 2000.
51. Brunham, R. C.; Rey-Ladino, J. Immunology of Chlamydia Infection: Implications for a Chlamydia Trachomatis Vaccine Nat. Rev. Immunol. 2005, 5, 149-161
52. Heijnen, I. A.; Van Vugt, M. J.; Fanger, N. A.; Graziano, R. F.; De Wit, T. P.; Hofhuis, F. M.; Guyre, P. M.; Capel, P. J.; Verbeek, J. S.; Van De Winkel, J. G. Antigen Targeting to Myeloid-Specific Human Fc Gamma RI/CD64 Triggers Enhanced Antibody Responses in Transgenic Mice J. Clin. Invest. 1996, 97, 331-338
53. Moore, T.; Ekworomadu, C. O.; Eko, F. O.; Macmillan, L.; Ramey, K.; Ananaba, G. A.; Patrickson, J. W.; Nagappan, P. R.; Lyn, D.; Black, C. M. et al. Fc Receptor-Mediated Antibody Regulation of T Cell Immunity Against Intracellular Pathogens J. Infect. Dis. 2003, 188, 617-624
54. Pal, S.; Peterson, E. M.; De La Maza, L. M. Vaccination with the Chlamydia Trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live Bacteria Infect. Immun. 2005, 73, 8153-8160
55. Ifere, G. O.; He, Q.; Igietseme, J. U.; Ananaba, G. A.; Lyn, D.; Lubitz, W.; Kellar, K. L.; Black, C. M.; Eko, F. O. Immunogenicity and Protection against Genital Chlamydia Infection and Its Complications by a Multisubunit Candidate Vaccine J. Microbiol. Immunol. Infect. 2007, 40, 188-200
56. Kelly, K. A.; Robinson, E. A.; Rank, R. G. Initial Route of Antigen Administration Alters the T-Cell Cytokine Profile Produced in Response to the Mouse Pneumonitis Biovar of Chlamydia Trachomatis Following Genital Infection Infect. Immun. 1996, 64, 4976-4983
57. Hansen, J.; Jensen, K. T.; Follmann, F.; Agger, E. M.; Theisen, M.; Andersen, P. Liposome Delivery of Chlamydia Muridarum Major Outer Membrane Protein Primes a Th1 Response That Protects Against Genital Chlamydial Infection in a Mouse Model J. Infect. Dis. 2008, 198, 758-767
58. Kar, U. K.; Jiang, J.; Champion, C. I.; Salehi, S.; Srivastava, M.; Sharma, S.; Rabizadeh, S.; Niazi, K.; Kickhoefer, V.; Rome, L. H. et al. Vault Nanocapsules as Adjuvants Favor Cell-Mediated Over Antibody-Mediated Immune Responses Following Immunization of Mice PLoS One 2012, 7, E38553
59. Carstens, M. G.; Camps, M. G.; Henriksen-Lacey, M.; Franken, K.; Ottenhoff, T. H.; Perrie, Y.; Bouwstra, J. A.; Ossendorp, F.; Jiskoot, W. Effect of Vesicle Size on Tissue Localization and Immunogenicity of Liposomal DNA Vaccines Vaccine 2011, 29, 4761-4770
60. Assudani, D.; Cho, H. I.; Devito, N.; Bradley, N.; Celis, E. In Vivo Expansion, Persistence, and Function of Peptide Vaccine-Induced CD8 T Cells Occur Independently of CD4 T Cells Cancer Res. 2008, 68, 9892-9899
61. Kar, U. K.; Srivastava, M. K.; Andersson, A.; Baratelli, F.; Huang, M.; Kickhoefer, V. A.; Dubinett, S. M.; Rome, L. H.; Sharma, S. Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth PLoS One 2011, 6, E18758
62. Gunn, M. D.; Tangemann, K.; Tam, C.; Cyster, J. G.; Rosen, S. D.; Williams, L. T.; Chemokine, A. Expressed in Lymphoid High Endothelial Venules Promotes the Adhesion and Chemotaxis of Naive T Lymphocytes Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 258-263
63. Warnock, R. A.; Campbell, J. J.; Dorf, M. E.; Matsuzawa, A.; Mcevoy, L. M.; Butcher, E. C. The Role of Chemokines in the Microenvironmental Control of T versus B Cell Arrest in Peyer's Patch High Endothelial Venules J. Exp. Med. 2000, 191, 77-88
64. Willimann, K.; Legler, D. F.; Loetscher, M.; Roos, R. S.; Delgado, M. B.; Clark-Lewis, I.; Baggiolini, M.; Moser, B. The Chemokine SLC Is Expressed in T Cell Areas of Lymph Nodes and Mucosal Lymphoid Tissues and Attracts Activated T Cells via CCR7 Eur. J. Immunol. 1998, 28, 2025-2034
65. Yoshida, R.; Nagira, M.; Kitaura, M.; Imagawa, N.; Imai, T.; Yoshie, O. Secondary Lymphoid-Tissue Chemokine Is a Functional Ligand for the CC Chemokine Receptor CCR7 J. Biol. Chem. 1998, 273, 7118-7122
66. Sharma, S.; Stolina, M.; Luo, J.; Strieter, R. M.; Burdick, M.; Zhu, L. X.; Batra, R. K.; Dubinett, S. M. Secondary Lymphoid Tissue Chemokine Mediates T Cell-Dependent Antitumor Responses in Vivo J. Immunol. 2000, 164, 4558-4563
67. Yang, S. C.; Hillinger, S.; Riedl, K.; Zhang, L.; Zhu, L.; Huang, M.; Atianzar, K.; Kuo, B. Y.; Gardner, B.; Batra, R. K. et al. Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity Clin. Cancer Res. 2004, 10, 2891-2901
68. Yang, S. C.; Batra, R. K.; Hillinger, S.; Reckamp, K. L.; Strieter, R. M.; Dubinett, S. M.; Sharma, S. Intrapulmonary Administration of CCL21 Gene-Modified Dendritic Cells Reduces Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma Cancer Res. 2006, 66, 3205-3213
69. Baratelli, F.; Takedatsu, H.; Hazra, S.; Peebles, K.; Luo, J.; Kurimoto, P. S.; Zeng, G.; Batra, R. K.; Sharma, S.; Dubinett, S. M. et al. Pre-clinical Characterization of GMP Grade CCL21-Gene Modified Dendritic Cells for Application in a Phase I Trial in Non-small Cell Lung Cancer J. Transl. Med. 2008, 6, 38
70. White, E.; Bienemann, A.; Taylor, H.; Hopkins, K.; Cameron, A.; Gill, S. A Phase I Trial of Carboplatin Administered by Convection-Enhanced Delivery to Patients with Recurrent/Progressive Glioblastoma Multiforme Contemp. Clin. Trials 2012, 33, 320-331
71. White, E.; Bienemann, A.; Pugh, J.; Castrique, E.; Wyatt, M.; Taylor, H.; Cox, A.; Mcleod, C.; Gill, S., An Evaluation of the Safety and Feasibility of Convection-Enhanced Delivery of Carboplatin into the White Matter as a Potential Treatment for High-Grade Glioma. J. Neurooncol. 108, 77-88.
72. Murata, S.; Kominsky, S. L.; Vali, M.; Zhang, Z.; Garrett-Mayer, E.; Korz, D.; Huso, D.; Baker, S. D.; Barber, J.; Jaffee, E. et al. Ductal Access for Prevention and Therapy of Mammary Tumors Cancer Res. 2006, 66, 638-645
73. Roa, W. H.; Azarmi, S.; Al-Hallak, M. H.; Finlay, W. H.; Magliocco, A. M.; Lobenberg, R., Inhalable Nanoparticles, a Non-invasive Approach To Treat Lung Cancer in a Mouse Model. J. Controlled Release 150, 49-55.
74. Yang, J.; Srinivasan, A.; Sun, Y.; Mrazek, J.; Shu, Z.; Kickhoefer, V. A.; Rome, L. H. Vault Nanoparticles Engineered with the Protein Transduction Domain, TAT48, Enhances Cellular Uptake Integr. Biol. (Cambridge) 2013, 5, 151-158
75. Patel, L. N.; Zaro, J. L.; Shen, W. C. Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives Pharm. Res. 2007, 24, 1977-1992
76. Torchilin, V. P. TAT Peptide-Mediated Intracellular Delivery of Pharmaceutical Nanocarriers Adv. Drug Delivery Rev. 2008, 60, 548-558
77. Zhang, X.; Wang, F. Intracellular Transduction and Potential of TAT PTD and Its Analogs: From Basic Drug Delivery Mechanism to Application Expert Opin. Drug Delivery 2012, 9, 457-472
78. Saha, R. N.; Vasanthakumar, S.; Bende, G.; Snehalatha, M. Nanoparticulate Drug Delivery Systems for Cancer Chemotherapy Mol. Membr. Biol. 2010, 27, 215-231
79. Samad, A.; Alam, M. I.; Saxena, K. Dendrimers: A Class of Polymers in The Nanotechnology for the Delivery of Active Pharmaceuticals Curr. Pharm. Des. 2009, 15, 2958-2969
80. Avgoustakis, K. Pegylated Poly(lactide) and Poly(lactide- co -glycolide) Nanoparticles: Preparation, Properties, and Possible Applications in Drug Delivery Curr. Drug Delivery 2004, 1, 321-333
81. Charman, W. N. Lipids, Lipophilic Drugs, and Oral Drug Delivery-Some Emerging Concepts J. Pharm. Sci. 2000, 89, 967-978
82. Buehler, D. C.; Toso, D. B.; Kickhoefer, V. A.; Zhou, Z. H.; Rome, L. H. Vaults Engineered for Hydrophobic Drug Delivery Small 2011, 7, 1432-1439
83. Bayburt, T. H.; Grinkova, Y. V.; Silgar, S. G. Self-Assembly of Discoidal Phospholipid Nanoparticles with Membrane Scaffold Proteins Nano Lett. 2002, 2, 853-856
84. Ryan, R. O. Nanodisks: Hydrophobic Drug Delivery Vehicles Expert Opin. Drug Delivery 2008, 5, 343-351
85. Oda, M. N.; Hargreaves, P. L.; Beckstead, J. A.; Redmond, K. A.; Van Antwerpen, R.; Ryan, R. O. Reconstituted High Density Lipoprotein Enriched with The Polyene Antibiotic Amphotericin B J. Lipid Res. 2006, 47, 260-267
86. Nelson, K. G.; Bishop, J. V.; Ryan, R. O.; Titus, R. Nanodisk-Associated Amphotericin B Clears Leishmania Major Cutaneous Infection in Susceptible BALB/C Mice Antimicrob. Agents Chemother. 2006, 50, 1238-1244
87. Redmond, K. A.; Nguyen, T. S.; Ryan, R. O. All-Trans-Retinoic Acid Nanodisks Int. J. Pharm. 2007, 339, 246-250
88. Singh, A. T.; Evens, A. M.; Anderson, R. J.; Beckstead, J. A.; Sankar, N.; Sassano, A.; Bhalla, S.; Yang, S.; Platanias, L. C.; Forte, T. M. et al. All Trans Retinoic Acid Nanodisks Enhance Retinoic Acid Receptor Mediated Apoptosis and Cell Cycle Arrest in Mantle Cell Lymphoma Br. J. Hamaetol. 2010, 150, 158-169
89. Iovannisci, D. M.; Beckstead, J. A.; Ryan, R. O. Targeting Nanodisks via a Single Chain Variable Antibody-Apolipoprotein Chimera Biochem. Biophys. Res. Commun. 2009, 379, 466-469
90. Napoli, J. L. Biochemical Pathways of Retinoid Transport, Metabolism, and Signal Transduction Clin. Immunol. Immunopathol. 1996, 80, S52-62
91. Soprano, D. R.; Qin, P.; Soprano, K. J. Retinoic Acid Receptors and Cancers Annu. Rev. Nutr. 2004, 24, 201-221
92. Clarke, N.; Germain, P.; Altucci, L.; Gronemeyer, H. Retinoids: Potential in Cancer Prevention and Therapy Expert Rev. Mol. Med. 2004, 6, 1-23
93. Okuno, M.; Kojima, S.; Matsushima-Nishiwaki, R.; Tsurumi, H.; Muto, Y.; Friedman, S. L.; Moriwaki, H. Retinoids in Cancer Chemoprevention Curr. Cancer Drug Targets 2004, 4, 285-298
94. Liu, P. T.; Krutzik, S. R.; Kim, J.; Modlin, R. L. Cutting Edge: All-Trans Retinoic Acid Down-Regulates TLR2 Expression and Function J. Immunol. 2005, 174, 2467-2470
95. Patatanian, E.; Thompson, D. F. Retinoic Acid Syndrome: A Review J. Clin. Pharm. Ther. 2008, 33, 331-338
96. Cai, W.; Zhao, H.; Guo, J.; Li, Y.; Yuan, Z.; Wang, W. Retinoic Acid-Induced Lumbosacral Neural Tube Defects: Myeloschisis and Hamartoma Childs Nerv. Syst. 2007, 23, 549-554
97. Tyner, K.; Sadrieh, N. Considerations when Submitting Nanotherapeutics to FDA/CDER for Regulatory Review Methods Mol. Biol. 2011, 697, 17-31
98. Eifler, A. C.; Thaxton, C. S. Nanoparticle Therapeutics: FDA Approval, Clinical Trials, Regulatory Pathways, and Case Study Methods Mol. Biol. 2011, 726, 325-338
99. Sadrieh, N.; Espandiari, P. Nanotechnology and the FDA: What Are the Scientific and Regulatory Considerations for Products Containing Nanomaterials? Nanotechnol. Law Bus. 2006, 3, 339-349
100. Kost, T. A.; Condreay, J. P.; Jarvis, D. L. Baculovirus as Versatile Vectors for Protein Expression in Insect and Mammalian Cells Nat. Biotechnol. 2005, 23, 567-575
101. Nishikawa, M.; Huang, L. Nonviral Vectors in the New Millennium: Delivery Barriers in Gene Transfer Hum. Gene Ther. 2001, 12, 861-870
102. Vijayanathan, V.; Thomas, T.; Thomas, T. J. DNA Nanoparticles and Development of DNA Delivery Vehicles for Gene Therapy Biochemistry 2002, 41, 14085-14094
103. Vandendriessche, T.; Thorrez, L.; Naldini, L.; Follenzi, A.; Moons, L.; Berneman, Z.; Collen, D.; Chuah, M. K. Lentiviral Vectors Containing the Human Immunodeficiency virus Type-1 Central Polypurine Tract Can Efficiently Transduce Nondividing Hepatocytes and Antigen-Presenting Cells in Vivo Blood 2002, 100, 813-822
104. Chuah, M. K.; Schiedner, G.; Thorrez, L.; Brown, B.; Johnston, M.; Gillijns, V.; Hertel, S.; Van Rooijen, N.; Lillicrap, D.; Collen, D. et al. Therapeutic Factor VIII Levels and Negligible Toxicity in Mouse and Dog Models of Hemophilia A Following Gene Therapy with High-Capacity Adenoviral Vectors Blood 2003, 101, 1734-1743
105. Xia, Y.; Ramgopal, Y.; Li, H.; Shang, L.; Srinivas, P.; Kickhoefer, V. A.; Rome, L. H.; Preiser, P. R.; Boey, F.; Zhang, H. et al. Immobilization of Recombinant Vault Nanoparticles on Solid Substrates ACS Nano 2012, 4, 1417-1424